Related references
Note: Only part of the references are listed.Sublingual misoprostol versus intravenous oxytocin in prevention of post-partum hemorrhage
Renu Tewatia et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2014)
Registration, procurement, distribution, and use of misoprostol in Uganda: an interview-based observational study
Esther C Atukunda et al.
LANCET (2013)
Effect on Postpartum Hemorrhage of Prophylactic Oxytocin (10 IU) by Injection by Community Health Officers in Ghana: A Community-Based, Cluster-Randomized Trial
Cynthia K. Stanton et al.
PLOS MEDICINE (2013)
Prevention of postpartum hemorrhage in low-resource settings: current perspectives
Ndola Prata et al.
INTERNATIONAL JOURNAL OF WOMENS HEALTH (2013)
Prevention of postpartum haemorrhage with sublingual misoprostol or oxytocin: a double-blind randomised controlled trial
M. B. Bellad et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2012)
Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women
Picklu Chaudhuri et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2012)
Prevention of postpartum hemorrhage with misoprostol
[Anonymous]
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2012)
Reporting of Noninferiority and Equivalence Randomized Trials Extension of the CONSORT 2010 Statement
Gilda Piaggio et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Rethinking WHO guidance: review of evidence for misoprostol use in the prevention of postpartum haemorrhage
Christina S. Chu et al.
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE (2012)
Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial
N. Mobeen et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2011)
High fever following postpartum administration of sublingual misoprostol
J. Durocher et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2010)
A randomized controlled trial of prophylactic sublingual misoprostol versus intramuscular methyl-ergometrine versus intramuscular 15-methyl PGF2 alpha in active management of third stage of labor
Arvind Vaid et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2009)
Misoprostol: Pharmacokinetic profiles, effects on the uterus and side-effects
O. S. Tang et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2007)
Misoprostol versus oxytocin for the reduction of postpartum blood loss
T. F. Baskett et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2007)
Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial
Richard J. Derman et al.
LANCET (2006)
Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section
N Vimala et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2006)
Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind clinical trial
L Hoj et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Sublingual misoprostol versus methylergometrine for active management of the third stage of labor
N Vimala et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2004)
WHO multicentre randomised trial of misoprostol in the management of the third stage of labour
AM Gülmezoglu et al.
LANCET (2001)
The revised CONSORT statement for reporting randomized trials: Explanation and elaboration
DG Altman et al.
ANNALS OF INTERNAL MEDICINE (2001)
Share Paper
